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ABSTRACT 
 
Male rat copulatory behavior is dependent on Testosterone (T) and its metabolites, estradiol (E2) 
and dihydrotestosterone (DHT). The estrogen receptor (ER) isoforms, ERα and ERβ, exist in the medial 
Amygdala (MEA) and either receptor might mediate mating behavior. Therefore, the effects of selective 
estrogenic MEA implants: propyl pyrazole triol (PPT, ERα agonist), diarylpropionitrile (DPN, ERβ agon-
ist), and 1-methyl-4-phenyl pyridinium (MPP, ERα antagonist) were compared to E2 in maintaining sex-
ual behavior. Four groups of male rats were castrated and administered DHT s.c. and bilateral MEA im-
plants containing either cholesterol, E2, PPT or DPN. An additional group of gonadally intact male rats 
received bilateral MPP-MEA implants. The post-surgical trials showed a significant decrease in the mat-
ing behavior of groups that received cholesterol, PPT, or DPN-MEA implants. However, sexual behavior 
was maintained in male rats that received the E2 or MPP-MEA implants. These results suggest a differen-
tial response of the MEA to E2. 
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INTRODUCTION 
Mammalian male sexual behavior depends on gonadal steroid hormones such as testosterone (T) 
and its metabolites [Christensen and Clemens, 1974; Davidson, 1969]. In the brain, testicular T is irre-
versibly converted into the active metabolites, dihydrotestosterone (DHT) via 5α-reductase [Massa et al., 
1972] and estradiol (E2) via aromatase [Naftolin et al., 1975]. Testosterone produced by testicular leydig 
cells facilitates the expression of male sexual behavior; however, the removal of the testes results in de-
creased sexual behavior [Davidson, 1966a, 1966b]. Exogenous T can restore mating behavior in castrated 
male rats [Christensen and Clemens, 1974; Davidson, 1966a, 1966b], and studies have shown that certain 
metabolites of T administered within physiological dose ranges can influence the expression of sexual 
behavior. Whereas neither exogenous E2 [Södersten, 1973] nor exogenous DHT [Davidson, 1966a; 
McGinnis and Dreifuss, 1989] administered alone completely restored mating behavior, a combination of 
E2 and DHT administered within the physiological dose range was as effective as T in restoring mating 
behavior in castrated male rats [Baum and Vreeburg, 1973]. Therefore, the androgenic and estrogenic me-
tabolites of T are necessary for the expression of mating behavior in male rats.  
Fadrozole, a non-steroid aromatase inhibitor [Lipton et al., 1990; Bonsall et al., 1992; Vagell and 
McGinnis, 1997], blocks the conversion of T to E2. When administered systemically [Bonsall et al., 1992] 
or locally into the medial amygdala (MEA) [Huddleston et al., 2006; Huddleston et al., 2003], Fadrozole 
decreases male rat mating behavior. Conversely, systemic administration of E2 [Bonsall et al., 1992] or 
E2-MEA implants [Huddleston et al., 2003] partially reversed this decrease in mating behavior. These 
studies suggest that, in the MEA, estrogen is required for the expression of male rat mating behavior. Es-
trogenic metabolites of T act on steroid sensitive neurons that express estrogen receptors (ERs) in both the 
medial preoptic area (MPO) [Clancy et al., 1995, 2000] and the MEA [Huddleston et al., 2003, 2006]. 
Two estrogen receptor (ER) isoforms, ERα and ERβ, exist in the MEA [Shughrue and Merchenthaler, 
2001; Greco et al., 2003] and either one of these ER subtypes might mediate the action of estrogen in the 
MEA. ER-Knock-Out (ERKO) experiments in male mice have shown that the deactivation of ERα signif-
icantly reduces mating behavior, while βERKO does not decrease mating behavior [Ogawa et al., 1997, 
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1998, 1999; Rissman et al., 1999]. However, in the combined knock-out, deactivation of both ERα and 
ERβ receptors completely eliminates all sexual behaviors of the male mice [Ogawa et al., 2000] which 
suggest that ERα plays a dominant role in the expression of mating behavior, whereas ERβ plays a minor 
role. Furthermore, ERα antisense oligodeoxynucleotide (AS-ODN) infusion of the MEA locally inhibited 
ERα expression in the MEA, but there was no significant decrease in the mating behavior of male rats 
[Paisley et al., 2005, Paisley, 2007]. In contrast, infusion of ERα AS-ODN to the MPO significantly de-
creased male rat mating behavior [Paisley, 2007; Paisley et al., 2005]. Based on these findings, we hy-
pothesized that the MEA responds differently to E2 than the MPO, and a different ER pathway, not ERα 
but perhaps ERβ, might mediate the sexual response of the male rat MEA to E2. 
Using selective estrogenic drugs, we tested the hypothesis by comparing the sexual behavior of 
castrated male rats before and after the drug implants into the MEA. Four groups of castrated DHT s.c. 
maintained male rats received bilateral MEA implants containing one of the following drugs: (i) choles-
terol (negative control), (ii) E2 (positive control), (iii) Propyl pyrazole triol (PPT, ERα agonist [Stauffer et 
al., 2000]) or (iv) Diarylpropionitrile (DPN, ERβ agonist [Meyers et al., 2001]). Additional gonadally in-
tact male rats received bilateral MEA implants containing Methyl-piperidino-pyrazole (MPP, ERα anta-
gonist [Sun et al., 2002]). We predicted that in the MEA, PPT, an ERα agonist would not maintain mating 
behavior as compared to E2, but DPN, an ERβ agonist would promote a better sexual response than PPT 
when compared to E2. In addition, we expected the group receiving MPP (ERα antagonist) implants to 
continue mating because previous studies have shown a greater role of ERα in the MPO than the MEA. 
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MATERIALS AND METHODS 
Animals 
Male and female Sprague Dawley rats obtained from Charles River Laboratories were housed 
separately in polycarbonate cages, 22 x 44 x 18 cm, with free access to food and water at Georgia State 
University. The rats were kept in a climate-controlled rat colony under a 14:10 hour reverse light-dark 
cycle (lights off at 0930h EST). Male rats were housed two per cage until surgery after which they were 
housed individually and females remained housed two per cage throughout the experiment. All mainten-
ance and surgical procedures were in accordance with Georgia State University IACUC and the NIH 
Guide for the Care and Use of Laboratory Animals (NIH Publ. No. 85-23, revised 1985). 
Female rats were anesthetized with isoflurane gas in a chamber (5% gas at 10 LPM oxygen ex-
change rate) and transferred to a nosecone (2-3% gas at 3 LPM oxygen). Females were ovariectomized 
through a single midline abdominal incision and implanted subcutaneously (s.c.) with a 6 mm Silastic 
capsule filled with crystalline E2. Postoperatively, the females received Penicillin (0.1 ml in benzathine 
penicillin G+ procaine penicillin G) to alleviate surgical pain and reduce the possibility of infection. The 
recovery time for the females was seven days before behavioral testing. They were injected with 1.0 mg 
s.c. progesterone (1 mg progesterone/0.2 ml sesame oil) 4-6 hours before being tested with males. 
In four weekly 30-minute mating tests, male rats were paired with receptive females and screened 
for sexual behavior for inclusion in the experiment. Proven ejaculators were matched based on total ejacu-
latory frequency and assigned to four groups: (i) E2-MEA (positive control), (ii) Cholesterol-MEA (nega-
tive control), (iii) PPT-MEA, and (iv) DPN-MEA. In addition, a fifth group consisting of gonadally intact 
male rats received MPP-MEA implants during postoperative trials. 
 
Male Sexual Behavior 
Male rats were paired with sexually receptive females during preoperative and postoperative mat-
ing tests for 30 minute in a 22 x 44 x 50 cm testing arena under dim red light. The behavioral testing be-
gan three hour after light off. Observers blind to the study recorded the following behaviors: mount fre-
4 
quency (MF- the number of mounts without penetration), intromission frequency (IF-the number of 
mounts with penetration), and ejaculation frequency (EF-the number of ejaculations). Observers also rec-
orded the mount latency (ML - time from the start of the test until the first mount or intromission or 1800 
seconds if no mount occurred), ejaculation latency (EL - time from the first mount or intromission until 
the first ejaculation or 1800 seconds if no ejaculation occurred), and post-ejaculatory interval (PEI - time 
between an ejaculation and the next mount or intromission or 1800 seconds if no ejaculation occurred). 
 
Administration of Selective Estrogenic Drugs into the MEA 
Groups of proven ejaculators were anesthetized with isoflurane gas and castrated through a single 
midline abdominal incision and implanted subcutaneously (s.c.) with a 10 mm Silastic capsule (1.981 mm 
ID x 3.175 mm OD) filled with crystalline DHT. Such DHT capsules have been reported to produce cir-
culating DHT levels in the physiological range [Ando et al., 1998; Lugg et al., 1995; Parte and Juneja, 
1992]. Immediately after castration and administering subcutaneous DHT capsules, the male rats were 
placed in a stereotaxic instrument and implanted bilaterally with 22-guage stainless steel, ethylene oxide 
sterilized guide cannulae aimed at the MEA (level skull coordinates: AP = -3.2 mm, ML = 3.5 mm, DV = 
-8.2 mm [Swanson, 1998]). Drug-carrying 28-guage sterile, stainless steel, inner cannulae were inserted 
through the guides and their tips extended 1 mm below the guide cannulae. These were tamped in either, 
E2, cholesterol, PPT, or DPN, sterilized, and inserted into the guide cannulae. A fifth group of gonadally 
intact male rats received MPP-MEA implants using the above stereotaxic procedure. All animals were 
given five to seven days to recover before weekly postoperative behavioral testing resumed. 48 hours be-
fore and 24 hours after every behavioral test, freshly tamped and sterilized drug-delivery inner cannulae 
were inserted into the brain under brief isoflurane anesthesia. Cannulae tips were inspected microscopi-
cally to ensure continuous brain exposure to the appropriate drug. When cannulae from the experimental 
animals were inspected, the drug was present at the cannulae tips at least 98% of the time. 
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Histological Verification 
After the postoperative behavioral tests, male rats were euthanized with an overdose of sodium 
pentobarbital (100 mg/kg i.p.) and perfused transcardially with physiological saline for five minutes fol-
lowed by a minimum of 300ml of a formalin fixative solution (pH 7.4). Skulls were partially opened and 
immersed overnight in perfusion fixative. Brains were removed from skulls the next day and stored in 
30% sucrose in 0.1 M PB for at least 48 hours. Frozen coronal brain sections (40 μm) through the dience-
phalon were collected into 0.1 M PB, mounted on gel-albumin-coated slides, and stained with toluene 
blue to verify cannulae placement.   
 
Statistical Analysis 
We analyzed between-group behavioral data from the pre-surgical period and separately during 
the post-surgical period using a one-way ANOVA analyses of variance, followed by post hoc compari-
sons using the Fisher least significant difference test at a probability level of 0.05 [Kirk, 1968].  Within-
group comparisons of pre-surgical and post-surgical changes in behavior were analyzed by paired t-tests 
[Kirk, 1968].  Data from all males were used in the statistical analyses; default values (see sexual beha-
vior tests) were used in situations where animals did not display a given behavior.  Two-tailed probabili-
ties are reported in all cases.   
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RESULTS 
Male Sexual Behavior 
After four to seven weeks of postoperative testing, the between group differences before and after 
surgery and the within group differences in sexual performance were determined by using the terminal 
pre-surgical sexual behavioral scores and the terminal post-surgical sexual behavioral scores. During the 
pre-surgical trials, all four groups mated robustly with no significant group difference in any of the beha-
vioral indices.  However, after surgery, groups administered PPT, DPN, or cholesterol-MEA implants 
mated significantly less frequently than the E2-MEA group which continued to mount vigorously (FIG-
URE 1). Significant group differences emerged in mount frequency (F3, 24 = 6.04, P < 0.003), intromission 
frequency (F3, 24 = 4.43, P < 0.013), and mount latency (F3, 24 = 5.12, P < 0.007) after surgery. Specifically, 
the between group post hoc analysis showed that after surgery the E2-MEA group mounted (P < 0.05) and 
intromitted significantly (P < 0.05) more often than the other three groups, and the E2-MEA group also 
had a significantly shorter (P < 0.05) mount latency than the DPN and cholesterol groups. This post hoc 
analysis of the E2, PPT, DPN and cholesterol groups also showed no significant group differences in eja-
culation frequency, ejaculation latency, or post-ejaculatory interval. Thus, E2-MEA implants in castrated, 
DHT s.c. maintained male rats supported mounting, whereas, the PPT, DPN, and cholesterol MEA im-
plants did not maintain mounting, intromission, or ejaculation. 
Subsequently, within group differences in mating behavior were examined before and after sur-
gery. In the E2-MEA group, there were no significant changes in mount frequency, mount latency or the 
post-ejaculatory interval before and after surgery; however, the intromission frequency (t = 2.49, P < 
0.047) and ejaculation frequency (t = 2.49, P < 0.047) were significantly lower after surgery, and the eja-
culation latency was significantly longer after surgery. The PPT-MEA group declined significantly in 
mount frequency (t = 2.55, P < 0.043) and intromission frequency (t = 4.32, P < 0.005), whereas, mount 
latency (t = 2.77, P < 0.032) and post-ejaculatory interval (t = 2.73, P < 0.034) were significantly longer 
during the post-surgical trials. In the DPN-MEA group, mount frequency (t = 2.73, P < 0.034), ejaculation   
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FIGURE 1: MALE SEXUAL BEHAVIOR.  Pre-surgical and post-surgical mating behaviors 
(MEAn ± standard error) of all groups. Castrated male rats given either PPT, DPN or cholesterol 
MEA implants mated significantly less than male rats that received E2-MEA implants during post-
surgical trials. Asterisks (*) indicate between group difference from estrogen (p< 0.05). Cross sym-
bol (+) indicates behaviors in which within group comparison of pre-surgical trials and terminal 
post-surgical trials differed significantly (p<0.05). 
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frequency (t = 4.5, P < 0.004) and intromission frequency (t = 5.23, P < 0.002) significantly decreased 
during the post-surgical trials, whereas the mount latency (t = 4.25, P < 0.005), ejaculation latency (t = 
3.26, P < 0.017) and post ejaculatory interval (t = 5.38, P < 0.002) significantly increased. Similarly, the 
cholesterol-MEA group showed a significant decline in mount frequency (t = 5.05, P < 0.002), ejaculation 
frequency (t = 4.58, P < 0.004) and intromission frequency (t = 7.72, P < 0.000) during post-surgical tri-
als, while mount latency (t = 14.4, P < 0.000), ejaculation latency (t = 3.96, P < 0.007), and post-
ejaculatory interval (t = 3.95, P < 0.008) became significantly longer. These results indicate that in con-
trast to E2-MEA implants which maintained mount frequency and mount latency, the MEA implants of 
PPT, DPN, or cholesterol alone did not maintain mating behavior in castrated male rats receiving DHT 
s.c. 
Finally, the terminal (week 4) pre-surgical mating behavior of the MPP-MEA group did not differ 
significantly from the terminal (week 5) post-surgical mating behavior in mount plus intromission fre-
quency (pre-surgical Mean ± SEM = 53.29 ± 2.73 versus post-surgical Mea n ± SEM = 47.14 ± 6.43, N = 
7, paired t-test = 1.24, p < 0.26, n.s.) or ejaculation frequency (pre-surgical Mean ± SEM = 2.14 ± 0.26 
versus post-surgical Mean ± SEM = 2.57 ± 0.48, N = 7, paired t-test = 1.16, p < 0.29, n.s.), which indi-
cates that MPP (an ERα antagonist) did not inhibit mating behavior following implantation into the MEA 
of gonadally intact male rats.  
 
 
Cannula Location 
The locations of cannulae tips within the MEA are shown in FIGURE 2. Cannulae tips were lo-
cated in or near the MEA in all groups of animals. 
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FIGURE 2: CANNULA LOCATION IN THE MEA. Cannulae tips were positioned in or near the 
MEA in all groups. The black dots represent the locations of the cannulae tips. 
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DISCUSSION 
During the post-surgical period, the mating behavior of the castrated male rats receiving DHT s.c. 
with either PPT (ERα agonist), DPN (ERβ agonist), or cholesterol (negative control) MEA implants sig-
nificantly decreased compared to those receiving E2 to the MEA. Pre-surgical versus post-surgical sexual 
behavior comparison revealed that animals implanted in the MEA with either PPT, DPN, or cholesterol 
had significant reductions in the number of mounts, intromissions and ejaculations. In contrast, male rats 
with the E2-MEA implants continued to mount robustly at levels that were not significantly different than 
the pre-surgical period. In addition, gonadally intact male rats receiving MPP-MEA implants continued to 
mate after surgery, and the pre-surgical and post-surgical frequencies of mounting, intromission, and eja-
culation did not differ significantly. 
 The purpose of this study was to test the hypothesis that the MEA responds differently to E2 than 
the MPO (in which ERα mediates the sexual response to E2 [Russell, 2010]), whereas, a different ER 
pathway, not ERα, but possibly ERβ might mediate the sexual response of the MEA to E2. Therefore, the 
behavioral effects of selective estrogenic MEA implants of PPT, DPN, MPP or cholesterol (negative con-
trol) were compared to the effects of E2 implants in the MEA. We predicted that DPN (ERβ agonist) im-
plants in the MEA would maintain mating behavior, whereas, PPT-MEA (ERα agonist) implants would 
not maintain the behavior. We also expected that MPP (ERα antagonist) would not interfere with mating 
behavior because a previous study showed that knock-down of ERα in the MEA did not reduce mating in 
male rats [Paisley, 2007]. Our hypothesis was partially supported. The results showed a significant de-
crease in the number of mounts and/or intromissions in all groups except those receiving E2 or MPP MEA 
implants which replicate previous findings that E2 in the MEA promotes mounting but not ejaculation 
[Huddleston et al., 2003]. However, our current data suggests that, in the MEA, neither ERα nor ERβ 
alone is sufficient for the expression of mating behavior in male rats. 
 E2 and synthetic ligands such as PPT, DPN, and MPP selectively bind different ER subtypes and 
elicit different responses [Stauffer et al., 2000]. In the MEA, E2 activates both ERα and ERβ and pro-
motes male sexual behavior. PPT has a greater binding affinity for ERα and limited cross reactivity with 
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ERβ [Stauffer et al., 2000], whereas DPN strongly binds ERβ with little cross reactivity with ERα [Mey-
ers et al., 2001]. Cholesterol is presumed to be inert and does not activate either ERα or ERβ, and as ex-
pected, the group that received cholesterol implants to the MEA ceased mating (FIGURE 1). MPP, an 
ERα antagonist, has a high binding affinity for ERα and little cross reactivity with ERβ [Sun et al., 2002], 
and as expected, it did not decrease mating behavior when implanted into the MEA. The outcome of these 
drugs in the MEA suggests that E2 indeed acts differently in the MEA than in the MPO. 
 The conversion of T to DHT by 5-alpha reductase [Massa et al., 1972] and of T to E2 by aroma-
tase is vital for the expression of sexual behavior in many male mammals [Naftolin et al., 1975; Whalen 
et al., 1985]. In castrated male rats, mating behavior is restored by exogenous T [Christensen and Cle-
mens, 1974; Davidson, 1966a, 1966b] or by combined treatment with DHT and E2 [Baum and Vreeburg, 
1973]. Moreover, the MEA is a critical brain region for the display of sexual behavior because bilateral 
lesions of the MEA cause severe deficits in male rat copulatory behavior [Kondo, 1992; Harris and Sachs, 
1975]. The MEA receives chemosensory inputs from the olfactory and accessory olfactory systems [Coo-
len et al., 1997; Canteras et al., 1995; Wood and Newman, 1995] along with somatosensory inputs from 
the genitals [Baum and Everitt, 1992; Gréco et al., 1999] to regulate male sexual behavior. The male rat 
MEA contains both androgen and estrogen sensitive neurons that are activated by mating [Gréco et al., 
1998]. Blocking the aromatization of T to E2 within the MEA via the infusion of fadrozole (an aromatase 
inhibitor) reduces mating [Huddleston et al., 2006; Huddleston et al., 2003] while E2 reverses this action 
[Huddleston et al., 2006]. In castrated male rats, E2-MEA implants restore mounting behavior alone [Ra-
sia-Filho et al., 1991] while in male hamsters, E2-MEA implants increase mounting and noncopulatory 
behaviors such as interaction with females, self-grooming, and ano-genital investigation [Wood, 1996]. 
Likewise, Huddleston et al., [2003] reported that E2 in the MEA facilitates mounting but not ejaculation. 
Our current data replicate and extend these previous studies by showing that E2 in the MEA supports 
mounting (FIGURE 1) which reflects sexual motivation in male rats. Although E2 in the MEA promotes 
mounting in castrated male rats, the MPO responds differently to E2. Lesions of the MPO result in the 
complete elimination of male rat sexual behavior [Liu et al., 1997b] while E2 implants in the MPO of 
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male rats maintains all components of  rodent sexual behavior (mounting, intromission, and ejaculation) 
[Clancy et al., 2000]. The MEA appears to play a role in sexual motivation by integrating chemosensory 
inputs from the olfactory systems, somatosensory and other sensory stimuli with hormonal pathways dur-
ing mating [Baum and Everitt, 1992; Canteras et al., 1995; Wood and Newman, 1995; Gréco et al. 1999].  
The MEA contains AR, ER, or AR colocalized with ER [Greco et al., 1998; Wood and Newman, 
1995] and ER exists in two isoforms, ERα and ERβ [Kuiper et al., 1996]. Estrogen sensitive neurons in 
the MEA have been shown to co-express ERα protein and ERβ mRNA [Shughrue et al., 1998]. ER-
Knock-Out (ERKO) studies in male mice showed that the deactivation of ERα significantly reduces mat-
ing behavior, while ERβKO does not greatly decrease mating behavior [Ogawa et al., 1997, 1998, 1999; 
Rissman et al., 1999]. Nevertheless, the combined knock-out of both ERα and ERβ receptors completely 
eliminates mating in male mice [Ogawa et al., 2000] which suggests a critical role for ERα and a minor 
role for ERβ in the expression of sexual behavior. Moreover, the inhibition of ERα expression in the 
MEA via AS-ODN infusion did not significantly affect mating in male rats [Paisley, 2007]. These pre-
vious findings together with our current results imply that neither ERα/ERα homodimerization nor 
ERβ/ERβ homodimerization in the MEA is necessary or sufficient for sexual behavior, but a combined 
ERα/ERβ related signal transduction pathway might mediate the sexual response of the MEA to E2; how-
ever, the mechanism by which E2 acts in the MEA is still unknown. Our present study does not address 
estrogen’s mechanism of action in the MEA, but Huddleston et al. [2006] suggests an intracellular me-
chanism of E2 action in the MEA. To determine if E2 mediates mating via the traditional pathway after 
binding intracellular receptors [Jensen et al., 1968; King and Green, 1984] or via binding to plasma mem-
brane ER [Pietras and Szego, 1977; Minami et al., 1990], the MEA of castrated, DHT maintained male 
rats was chronically administered bilateral implants of E2 conjugated to bovine serum albumin (BSA-E2) 
[Huddleston et al. 2006]. BSA is a large protein that does not cross the plasma membrane. Therefore, the 
complex of E2 and BSA restricts the action of E2 to cell surface signaling by blocking E2 diffusion across 
the plasma membrane [Pappas et al., 1995]. Huddleston et al. [2006] showed that chronic delivery of 
BSA-E2 to the MEA does not maintain copulatory behavior, whereas free E2 administered to the MEA 
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promotes mounting in male rats; this suggests that E2 acts intracellularly within the MEA rather than at 
the plasma membrane. In contrast, E2 mediates copulatory behavior via plasma membrane bound ER in 
the MPO, specifically ERα [Huddleston et al., 2006; Russell 2010].  
In conclusion, we expected that ERβ would mediate the sexual response of the MEA to E2, but E2 
did not facilitate mating via the ERα or ERβ pathway alone. The findings of this study led us to believe 
that E2 in the MEA is necessary for sexual motivation (as reflected by mounting) but not ejaculatory per-
formance, whereas other studies suggest that estrogen mediates ejaculatory performance by acting in the 
MPO not the MEA. Potentially, no single E2 receptor pathway in the MEA is necessary for the expression 
of male rat sexual behavior, but several different ER subtypes might work together in an additive fashion 
to regulate sexual motivation.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
14 
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